Cite
HARVARD Citation
Dermawan, J. et al. (2022). FGFR2::TACC2 fusion as a novel KIT‐independent mechanism of targeted therapy failure in a multidrug‐resistant gastrointestinal stromal tumor. Genes, chromosomes & cancer. 61 (7), pp. 412-419. [Online].